Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein light chain LC8-type 1 pseudogene 1 (DYNLL1P1)
- Target
- DYNLL1P1
- Molecular classification
- Other (Pseudogene)
01
Overview
**Dynein light chain LC8-type 1 pseudogene 1** (DYNLL1P1) is a noncoding pseudogene in humans, meaning it is a DNA segment similar to the functional DYNLL1 gene but is not translated into a protein product[1][10][8]. Pseudogenes like DYNLL1P1 can resemble their functional gene counterparts in sequence but are rendered nonfunctional due to disabling mutations such as frameshifts or premature stop codons[8]. DYNLL1P1 is sometimes referenced in research involving transcriptomic signatures, where expression of such pseudogenes has been linked as biomarkers in oncology for prognosis or response prediction[6]. However, DYNLL1P1 does not encode a functional protein and is not considered a therapeutic target, enzyme, receptor, transporter, or similar druggable entity[1][8][10].
- Other names
- DNCL1P1dyneincytoplasmiclight chainLC8-type 1 pseudogene 1
02
Biological functions
Other (nonfunctional pseudogene, no protein product)
03
Disease associations
Other (serves as prognostic biomarker in some cancers)
04
Biomarkers
May be included in immune-related pseudogene signatures for prognosis in some cancers[6]
Beyond the preview
Go deeper on Dynein light chain LC8-type 1 pseudogene 1 (DYNLL1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dynein light chain LC8-type 1 pseudogene 1 (DYNLL1P1).